WHIPPANY, NJ--(Marketwired - Oct 26, 2016) -  Michael James Enterprises, Inc. (OTCQB: MJTV), is pleased to report that it just filed for trademark protection for its female sexual arousal enhancer - Voluptas. Dr. Kristina Kinkaid will also begin a series of Voluptas - The Sexuality Project classes, conferences and workshops.

The Voluptas Sexuality Project is initially expected to run once a month and will begin traveling to cities throughout the United States in the first half of 2017 and eventually Western Europe. The date of the first workshop is to be set in the next few weeks, but just from word of mouth is being close to being sold out. MJTV is exploring the idea of increasing the size of each workshop.

MJTV is currently working on its packaging and artwork for the Voluptas product as well as finalizing the exact product and manufacturing costs. MJTV is still on course to have the Voluptas product ready for market in the first quarter of 2017. The Voluptas Sexuality Project series is starting soon to begin the pre-branding of the Voluptas product.

Brand Ambassador, Dr. Kristina Kincaid, stated, "I gave out samples of Voluptas to several of my friends (former Victoria Secret models) and that night and even the next morning they were astonished with the results. Additionally, the response has been incredible so far just in preparing for the start of our Voluptas Sexuality Project series and we have not even begun to do any marketing. I am so excited to be a part of this because it is just so explosive and exciting."

Safe Harbor Statement

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason.